Possible Pitfalls of Ipilimumab Therapy in Malignant Melanoma - a Case Report

Abstract

Metastatic melanoma is a malignancy with one of the hignest mortality rates. However, with the introduciton of new drugs during the last decade, the prognosis of patients began to improve.

We present a case of 68-year-old women with metastatic melanoma who uderwent treatment with ipilimumab.

Keywords

• melanoma
• ipilimumab
• hypohysitis
• CTLA-4